Sandra Silberman, MD, PhD
Basic profileManaging Partner, SLS Oncology LLC (Durham, NC), per Crunchbase · Hematology / Oncology
Sandra Silberman is Managing Partner, SLS Oncology LLC (Durham, NC), per Crunchbase. OpenAlex indexes 64 publications with 13,588 citations (h-index 18); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Updated 25 Oct 2026
Sandra Silberman, MD PHD, is Managing Partner, SLS Oncology LLC (Durham, NC), per Crunchbase. The public record shows 64 publications with 13,588 citations (h-index 18), centered on Lymphoma, Breast Cancer, Hodgkin Disease. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Lymphoma
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
207 Booth Meadow Ln
Durham, NC 27713-5810
Telephone
919-884-6609Registry record last updated 29 Nov 2016 · collected 28 Jul 2026.
Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Sponsor: CNS Pharmaceuticals, Inc.
- Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
Sponsor: Moleculin Biotech, Inc.
- A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer
Sponsor: Cortice Biosciences, Inc.
Industry payments
Updated 25 Oct 2026
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Telix PharmaceuticalsProgram year20231 payment
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →everydayhealth.care ↗
- PhD in Tumor Immunology
Johns Hopkins University
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →crunchbase.com ↗ - MD
Cornell University Medical College
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →crunchbase.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →1stoncology.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthmanagement.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”